Clinical Trials In Illinois
Discover hundreds of clinical trials in Illinois.
Search clinical trials in Illinois by city, condition or phase.
Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer
Sponsor:
Agennix
Location:
Code:
NCT00706862
Conditions
Non Small Cell Lung Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Talactoferrin
Placebo
JSP191 Antibody Conditioning Regimen in MDS/AML Subjects Undergoing Allogenic Hematopoietic Stem Cell Transplantation
Sponsor:
Jasper Therapeutics, Inc.
Location:
Code:
NCT04429191
Conditions
MYELODYSPLASTIC SYNDROME; MDS
ACUTE MYELOID LEUKEMIA; AML
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Humanized anti-CD117 Monoclonal Antibody (JSP191)
Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents
Sponsor:
AstraZeneca
Location:
Code:
NCT06120491
Conditions
Metastatic Castration-Sensitive Prostate Cancer
Eligibility Criteria
Sex: Male
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Saruparib
Placebo
Abiraterone Acetate
Darolutamide
Enzalutamide
A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
Sponsor:
Hoffmann-La Roche
Location:
Code:
NCT04873362
Conditions
Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Atezolizumab
Trastuzumab Emtansine
Placebo
Trastuzumab
Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer
Sponsor:
Oana Danciu
Location:
Code:
NCT05467891
Conditions
Locoregional Recurrence
Hormone Receptor-positive Breast Cancer
HER2-negative Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Ribociclib
Fulvestrant
Anastrozole
Letrozole
Exemestane
A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough
Sponsor:
Bellus Health Inc. - a GSK company
Location:
Code:
NCT05599191
Conditions
Refractory Chronic Cough
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
BLU-5937
Placebo
Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT05691491
Conditions
Advanced Malignant Solid Neoplasm
Advanced Microsatellite Stable Colorectal Carcinoma
Hematopoietic and Lymphatic System Neoplasm
Metastatic Malignant Solid Neoplasm
Metastatic Microsatellite Stable Colorectal Carcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Biopsy
Biospecimen Collection
Computed Tomography
Magnetic Resonance Imaging
Temozolomide
Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON)
Sponsor:
Edgewise Therapeutics, Inc.
Location:
Code:
NCT05291091
Conditions
Becker Muscular Dystrophy
Eligibility Criteria
Sex: Male
Age: 12 - 50
Healthy Volunteers: Not accepted
Interventions
Sevasemten 10 mg
Sevasemten 5 mg
Sevasemten 12.5 mg
Placebo
Zimmer Biomet Shoulder Arthroplasty PMCF
Sponsor:
Zimmer Biomet
Location:
Code:
NCT04984291
Conditions
Shoulder Fractures
Shoulder Arthritis
Shoulder Osteoarthritis
Shoulder Deformity
Shoulder Injuries
Eligibility Criteria
Sex: All
Age: 20+
Healthy Volunteers: Not accepted
Interventions
Alliance Glenoid
Identity Stem
Response to Exercise and Nitric Oxide in PAD
Sponsor:
Northwestern University
Location:
Code:
NCT06657976
Conditions
Peripheral Artery Disease
Exercise
Intermittent Claudication
Nitric Oxide
Eligibility Criteria
Sex: All
Age: 50+
Healthy Volunteers: Not accepted
Interventions
Supervised Treadmill Exercise
Attention Control
Nitrate-Rich Beetroot Juice + supervised exercise therapy
Placebo + supervised exercise therapy